Geoffrey B. Dreyer

2.3k citations

32 papers · 1.9k indexed · h-index 19

Co-authors: Peter B. Dervan Brian W. Metcalf Michael L. Moore Thomas D. Meek Paul A. Wender James E. Strickler Thaddeus A. Tomaszek Christine Debouck
Topics: HIV/AIDS drug development and treatment (21 papers)HIV Research and Treatment (20 papers)Carbohydrate Chemistry and Synthesis (5 papers)
Cited by: Virology Infectious Diseases Organic Chemistry
Journals: Nature Proceedings of the National Academy of Sciences Journal of the American Chemical Society
Partner nations: United States Norway

In The Last Decade

Geoffrey B. Dreyer

32 papers receiving 1.8k citations

Peers

Countries citing papers authored by Geoffrey B. Dreyer

Since Specialization

Citations

This map shows the geographic impact of Geoffrey B. Dreyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geoffrey B. Dreyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geoffrey B. Dreyer more than expected).

Fields of papers citing papers by Geoffrey B. Dreyer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geoffrey B. Dreyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geoffrey B. Dreyer. The network helps show where Geoffrey B. Dreyer may publish in the future.

Co-authorship network of co-authors of Geoffrey B. Dreyer

This figure shows the co-authorship network connecting the top 25 collaborators of Geoffrey B. Dreyer. A scholar is included among the top collaborators of Geoffrey B. Dreyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geoffrey B. Dreyer. Geoffrey B. Dreyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Actinonin, a Naturally Occurring Antibacterial Agent, Is a Potent Deformylase Inhibitor 2000 ·Biochemistry ·(unknown),Dinesh V. Patel,C J Hackbarth,Wen Wang,Geoffrey B. Dreyer,Dennis C. Young,Peter S. Margolis,Charlotte Wu,(unknown),Joaquim Trias,Richard White,Zhengyu Yuan	237
2	Potent Inhibition of HIV Type 1 Infection of Mononuclear Phagocytes by Synthetic Peptide Analogs of HIV Type 1 Protease Substrates 1996 ·AIDS Research and Human Retroviruses ·(unknown),Thomas J. Matthews,Dennis M. Lambert,Geoffrey B. Dreyer,Stephen R. Petteway,Jason B. Weinberg	2
3	Effects of SKF 108922, an HIV-1 protease inhibitor, on retrovirus replication in mice 1996 ·Antiviral Research ·Paul L. Black,Michael A. Ussery,Shawn Barney,Robert J. Wittrock,(unknown),Geoffrey B. Dreyer,Stephen R. Petteway,(unknown),(unknown),Dennis M. Lambert	3
4	The Pseudocalanolides: Structure Revision of Calanolides C and D 1995 ·Journal of Natural Products ·Tawnya C. McKee,John H. Cardellina,Geoffrey B. Dreyer,Michael R. Boyd	18
5	A convenient synthesis of di- and trisubstituted γ-pyrones 1993 ·Tetrahedron Letters ·George Majetich,Yong Zhang,Geoffrey B. Dreyer	9
6	A symmetric inhibitor binds HIV-1 protease asymmetrically 1993 ·Biochemistry ·Geoffrey B. Dreyer,Jeffrey C. Boehm,Balan Chenera,Renée L. DesJarlais,Anne M. Hassell,Thomas D. Meek,Thaddeus A. Tomaszek,(unknown)	58
7	Synergistic drug interactions of an HIV-1 protease inhibitor with AZT in different in vitro models of HIV-1 infection 1993 ·Antiviral Research ·D.M. Lambert,H F Bartus,(unknown),(unknown),Jeffry J. Leary,Geoffrey B. Dreyer,Brian W. Metcalf,Stephen R. Petteway	16
8	Antiretroviral activities of protease inhibitors against murine leukemia virus and simian immunodeficiency virus in tissue culture 1993 ·Antimicrobial Agents and Chemotherapy ·Paul L. Black,(unknown),Mark G. Lewis,Michael A. Ussery,Geoffrey B. Dreyer,Stephen R. Petteway,D.M. Lambert	12
9	Effect of a Human Immunodeficiency Virus Protease Inhibitor on Human Monocyte Function 1992 ·AIDS Research and Human Retroviruses ·Peter J. Bugelski,Johanne Kaplan,Timothy K. Hart,Joanne M. Miller,Jeffrey T. Laydon,John C. Lee,Geoffrey B. Dreyer,Richard Kirsh	18
10	Hydroxyethylene isostere inhibitors of human immunodeficiency virus-1 protease: structure-activity analysis using enzyme kinetics, x-ray crystallography, and infected T-cell assays 1992 ·Biochemistry ·Geoffrey B. Dreyer,Dennis M. Lambert,Thomas D. Meek,Thomas J. Carr,Thaddeus A. Tomaszek,Annabellee V. Fernandez,H F Bartus,(unknown),(unknown)	110
11	Proteolysis of an active site peptide of lactate dehydrogenase by human immunodeficiency virus type 1 protease 1992 ·Biochemistry ·Thaddeus A. Tomaszek,Michael L. Moore,James E. Strickler,(unknown),(unknown),Brian W. Metcalf,Anne M. Hassell,Geoffrey B. Dreyer,(unknown)	35
12	Effect of retroviral proteinase inhibitors on Mason-Pfizer monkey virus maturation and transmembrane glycoprotein cleavage 1992 ·Journal of Virology ·Maja A. Sommerfelt,Stephen R. Petteway,Geoffrey B. Dreyer,Eric Hunter	38
13	Purification and biochemical characterization of recombinant simian immunodeficiency virus protease and comparison to human immunodeficiency virus type 1 protease 1991 ·Biochemistry ·(unknown),Ingrid C. Deckman,Michael D. Minnich,Jeffrey S. Culp,Samuel P. Franklin,Geoffrey B. Dreyer,Thaddeus A. Tomaszek,Christine Debouck,Thomas D. Meek	42
14	Synthesis of C2-symmetric and pseudosymmetric HIV-1 protease inhibitors from D-arabitol 1991 ·Bioorganic & Medicinal Chemistry Letters ·Balan Chenera,Jeffrey C. Boehm,Geoffrey B. Dreyer	38
15	HIV‐1 Protease as a Potential Target for Anti‐AIDS Therapy 1990 ·Annals of the New York Academy of Sciences ·Thomas D. Meek,Geoffrey B. Dreyer	14
16	Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues 1990 ·Nature ·Thomas D. Meek,Dennis M. Lambert,Geoffrey B. Dreyer,Thomas J. Carr,Thaddeus A. Tomaszek,Michael L. Moore,James E. Strickler,Christine Debouck,(unknown),Thomas J. Matthews,Brian W. Metcalf,Stephen R. Petteway	201
17	Human immunodeficiency virus 1 protease expressed in Escherichia coli behaves as a dimeric aspartic protease. 1989 ·Proceedings of the National Academy of Sciences ·Thomas D. Meek,Brian D. Dayton,Brian W. Metcalf,Geoffrey B. Dreyer,James E. Strickler,Joselina Gorniak,Martin Rosenberg,Michael L. Moore,Victoria W. Magaard,Christine Debouck	155
18	Peptide substrates and inhibitors of the HIV-1 protease 1989 ·Biochemical and Biophysical Research Communications ·Michael L. Moore,(unknown),Stephen A. Fakhoury,Victoria W. Magaard,William F. Huffman,Brian D. Dayton,Thomas D. Meek,(unknown),Geoffrey B. Dreyer,Brian W. Metcalf,James E. Strickler,Joselina Gorniak,Christine Debouck	145
19	α,α-Difluoroketone inhibitors of HMG CoA reductase 1988 ·Tetrahedron Letters ·Geoffrey B. Dreyer,Brian W. Metcalf	33
20	Synthetic studies on arene-olefin cycloadditions. 4. Total synthesis of (.+-.)-modhephene 1982 ·Journal of the American Chemical Society ·Paul A. Wender,Geoffrey B. Dreyer	65

About Geoffrey B. Dreyer

Geoffrey B. Dreyer is a scholar working on Virology, Infectious Diseases and Organic Chemistry, having authored 32 papers that have together received 1.9k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (21 papers), HIV Research and Treatment (20 papers) and Carbohydrate Chemistry and Synthesis (5 papers). The work is most often cited by research in Virology (768 citations), Infectious Diseases (843 citations) and Organic Chemistry (620 citations). Geoffrey B. Dreyer has collaborated with scholars based in United States and Norway. Frequent co-authors include Peter B. Dervan, Brian W. Metcalf, Michael L. Moore, Thomas D. Meek, Paul A. Wender, James E. Strickler, Thaddeus A. Tomaszek, Christine Debouck, Thomas J. Carr and Victoria W. Magaard. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact